The meeting, scheduled for June 25-26, will review existing data and vote on RSV and influenza vaccines, along with ...

Nearly three-quarters of infants were immunized against respiratory syncytial virus through maternal vaccination or ...

U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisers began their first meeting Wednesday under intense scrutiny ...

A federal vaccine advisory committee plans to review the childhood vaccination schedule and scrutinize vaccines that have ...

This builds upon its initial approval in May 2024 for adults aged 60 years and older, which makes mRESVIA the second approved ...

In opening Wednesday’s meeting, newly appointed ACIP chair Martin Kulldorff, Ph.D., leaned into the controversy surrounding U.S. vaccine policy following the COVID-19 pandemic and, more recently, ...

The letter, signed by 79 medical societies, expresses concern over recent federal immunization review policies and asks that vaccines remain available to patients without cost-sharing.

A virus that once filled pediatric hospital beds and terrified new parents is finally being pushed back—before babies are ...

The FDA has expanded the approval of mResvia to include active immunization in high-risk individuals 18 through 59 years of age.

U.S. vaccine advisers will discuss recommendations for flu vaccines containing the preservative thimerosal and a combination ...